| Health / Medical Topics |
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid…
A nine amino acid peptide fragment of carcinoembryonic antigen (CEA), a protein that is overexpressed in several cancer cell types, including gastrointestinal,…
A class of synthetic peptides based on the sequences of carcinoembryonic antigen (CEA), a tumor-associated antigen overexpressed in several cancer cell…
The determination of the amount of carcinoembryonic antigen present in a sample.
A laboratory test that measures the level of carcinoembryonic antigen (CEA) in the blood. An increased amount of CEA may be found…
A substance that may be found in the blood of people who have colon cancer, other types of cancer or diseases, or…
